CellChorus Patents

Patent portfolio assigned to CellChorus (verified via public assignee records). Dynamic single-cell analysis via TIMING platform (US). CellChorus' own About page states tech is 'protected in part by issued patents and pending patent applications, including US/10,746,736', so has_patents=true; exact count not disclosed. Customers described generically (top-25 biopharma) but none named; no clean sourced competitor list.